Mohamed. A. Omar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Mohamed. A. Omar has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Aladdin M. Srour
Department of Therapeutic Chemistry, National Research Centre, Dokki, Cairo, 12622, Egypt
3 shared publications Jürgen Conrad
Bioorganische Chemie, Institut für Chemie, Universität Hohenheim, Garbenstraße 30, D-70599 Stuttgart, Germany
3 shared publicationsUwe Beifuss
Bioorganische Chemie, Institut für Chemie, Universität Hohenheim, Garbenstraße 30, D-70599 Stuttgart, Germany
3 shared publications- Ahmed Temirak
Chemistry of Natural and Microbial products Department, Pharmaceutical and Drug Industries Research Institute, National Research Centre, Dokki, Giza, 12622, Egypt
2 shared publications - Asmaa Fathy Abd Elaziz Kassem
Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia
2 shared publications - Eman Samir Nossier
Pharmaceutical Medicinal Chemistry and Drug Design Department, Faculty of pharmacy (Girls), Al-Azhar University, Cairo, Egypt
2 shared publications
Latest Publications
- 25 June 2026
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (15) , 1-15
Indole-based carbohydrazides as potent anti-proliferative leads and tubulin polymerization inhibitors: design, synthesis, cytotoxic evaluation, in silico ADMET and docking studies
A novel series of indolecarbohydrazide derivatives (3a-r) was designed and synthesized to evaluate their potential as tubulin polymerization inhibitors and selective anticancer agents. The cytotoxic potential of compounds 3a-r was assessed against six human cancer cell lines and nonmalignant RPE-1 cells. Mechanistic studies included tubulin polymerization assays, cell cycle analysis, and apoptosis induction. Pharmacokinetic profiles were predicted using SwissADME, while molecular docking (MOE-Dock v2024.0601) explored binding affinities at the colchicine site. Compounds 3b, 3d, 3i, and 3p showed significant potency against MCF-7 cells, with 3i being the most active (IC50 = 1.0 ± 0.05 mM), outperforming doxorubicin. Derivatives 3d and 3i effectively inhibited tubulin polymerization (IC50 = 3.96 and 6.28 μM, respectively), comparable to combretastatin A4. Compound 3d induced G2/M phase arrest and apoptosis, consistent with microtubule disruption. In silico analysis predicted favorable drug-like properties, and docking scores (-9.28 to -10.92 kcal/mol) confirmed high affinity for the colchicine binding site. These findings identify the indolecarbohydrazide scaffold as a potent anti-proliferative lead that successfully disrupts tubulin dynamics, offering a promising foundation for further development of colchicine-site microtubule-targeting agents.
- 25 June 2026
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 18 (15) , 1-15
Indole-based carbohydrazides as potent anti-proliferative leads and tubulin polymerization inhibitors: design, synthesis, cytotoxic evaluation, in silico ADMET and docking studies
A novel series of indolecarbohydrazide derivatives (3a-r) was designed and synthesized to evaluate their potential as tubulin polymerization inhibitors and selective anticancer agents. The cytotoxic potential of compounds 3a-r was assessed against six human cancer cell lines and nonmalignant RPE-1 cells. Mechanistic studies included tubulin polymerization assays, cell cycle analysis, and apoptosis induction. Pharmacokinetic profiles were predicted using SwissADME, while molecular docking (MOE-Dock v2024.0601) explored binding affinities at the colchicine site. Compounds 3b, 3d, 3i, and 3p showed significant potency against MCF-7 cells, with 3i being the most active (IC50 = 1.0 ± 0.05 mM), outperforming doxorubicin. Derivatives 3d and 3i effectively inhibited tubulin polymerization (IC50 = 3.96 and 6.28 μM, respectively), comparable to combretastatin A4. Compound 3d induced G2/M phase arrest and apoptosis, consistent with microtubule disruption. In silico analysis predicted favorable drug-like properties, and docking scores (-9.28 to -10.92 kcal/mol) confirmed high affinity for the colchicine binding site. These findings identify the indolecarbohydrazide scaffold as a potent anti-proliferative lead that successfully disrupts tubulin dynamics, offering a promising foundation for further development of colchicine-site microtubule-targeting agents.
- 16 July 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (16) , 1615-1631
Barbiturate–sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies
Aim: Design and synthesis of a series of 5-benzylidene(thio)barbiturates 3a-r. Methodology: Evaluation of the inhibitory activity of the new chemical entities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using Donepezil as the standard reference. Results & Conclusion: Compound 3r emerged as the most potent AChE inhibitor (IC50 = 9.12 μM), while compound 3q exhibited the highest inhibitory activity against BChE (IC50 = 19.43 μM). Toxicological bioassays confirmed the absence of cytotoxicity for the most potent compounds at the tested doses. Molecular docking analysis demonstrated that the tested derivatives effectively bind to the active sites of both enzymes. Overall, this study sheds light on the potential of barbiturate-sulfonate conjugates as promising drug candidates.
- 16 July 2024
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 16 (16) , 1615-1631
Barbiturate–sulfonate hybrids as potent cholinesterase inhibitors: design, synthesis and molecular modeling studies
Aim: Design and synthesis of a series of 5-benzylidene(thio)barbiturates 3a-r. Methodology: Evaluation of the inhibitory activity of the new chemical entities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) using Donepezil as the standard reference. Results & Conclusion: Compound 3r emerged as the most potent AChE inhibitor (IC50 = 9.12 μM), while compound 3q exhibited the highest inhibitory activity against BChE (IC50 = 19.43 μM). Toxicological bioassays confirmed the absence of cytotoxicity for the most potent compounds at the tested doses. Molecular docking analysis demonstrated that the tested derivatives effectively bind to the active sites of both enzymes. Overall, this study sheds light on the potential of barbiturate-sulfonate conjugates as promising drug candidates.
- 23 November 2023
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 15 (24) , 2269-2287
Hydrazone–Sulfonate Hybrids as Potential Cholinesterase Inhibitors: Design, Synthesis and Molecular Modeling Simulation
Aim: Design and synthesis of a series of hydrazone–sulfonate hybrids, 5a–r. Methodology: The inhibitory properties of the synthesized compounds against acetylcholinesterase and butyrylcholinesteras...
- 23 November 2023
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 15 (24) , 2269-2287
Hydrazone–Sulfonate Hybrids as Potential Cholinesterase Inhibitors: Design, Synthesis and Molecular Modeling Simulation
Aim: Design and synthesis of a series of hydrazone–sulfonate hybrids, 5a–r. Methodology: The inhibitory properties of the synthesized compounds against acetylcholinesterase and butyrylcholinesteras...
- 9 December 2019
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 57 (2) , 731-743
Synthesis of furo[3,2‐g]chromones under microwave irradiation and their antitumor activity evaluation
A series of furo[3,2‐g]chromone derivatives were synthesized via the reaction of furochromone carbaldehyde 1 with amines 3a‐d and thioglycolic acid to give thiazolidinones 4a‐d. The later react with benzaldehyde/thiourea or hydroxylamine and DMF‐DMA in glacial acetic acid to give thiazolopyrimidines 5a‐d or thiazoloisoxazoles 6a‐d, respectively. Also, the synthesis of α‐aminophosphonates via the one‐pot reaction of 1 and amines 3a,b were trapped by dialkylphosphites 7a‐c afforded the corresponding α‐aminophosphonates 8a‐f. Applying hexaalkyltriamidophosphites 9a,b to 1 gives alkylidenephosphorane ylides 11a,b in an open structure form. In the present investigation, the in vitro inhibition capacity of compounds (4a, 4c, 5b, 5c, 6b‐d, 8a‐f, and 11a) was screened in three human cancer cell lines HCT‐116, MCF‐7, and HepG2. The anticancer activity results revealed that 8b and 8e had more potent cytotoxic inhibition activity against HCT‐116 cell line; however, all the tested compounds had obviously less cytotoxic activity against MCF‐7 cell line, while 5b, 5c, and 6d were potent against HepG2 cell line compared with that of doxorubicin.
- 9 December 2019
- Published by Wiley in Journal of Heterocyclic Chemistry
- Vol. 57 (2) , 731-743
Synthesis of furo[3,2‐g]chromones under microwave irradiation and their antitumor activity evaluation
A series of furo[3,2‐g]chromone derivatives were synthesized via the reaction of furochromone carbaldehyde 1 with amines 3a‐d and thioglycolic acid to give thiazolidinones 4a‐d. The later react with benzaldehyde/thiourea or hydroxylamine and DMF‐DMA in glacial acetic acid to give thiazolopyrimidines 5a‐d or thiazoloisoxazoles 6a‐d, respectively. Also, the synthesis of α‐aminophosphonates via the one‐pot reaction of 1 and amines 3a,b were trapped by dialkylphosphites 7a‐c afforded the corresponding α‐aminophosphonates 8a‐f. Applying hexaalkyltriamidophosphites 9a,b to 1 gives alkylidenephosphorane ylides 11a,b in an open structure form. In the present investigation, the in vitro inhibition capacity of compounds (4a, 4c, 5b, 5c, 6b‐d, 8a‐f, and 11a) was screened in three human cancer cell lines HCT‐116, MCF‐7, and HepG2. The anticancer activity results revealed that 8b and 8e had more potent cytotoxic inhibition activity against HCT‐116 cell line; however, all the tested compounds had obviously less cytotoxic activity against MCF‐7 cell line, while 5b, 5c, and 6d were potent against HepG2 cell line compared with that of doxorubicin.
- 27 August 2015
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 30 (5) , 826-845
Synthesis,in vitroandin vivoantitumor and antiviral activity of novel 1-substituted benzimidazole derivatives
A novel series of 5-nitro-1H-benzimidazole derivatives substituted at position 1 by heterocyclic rings was synthesized. Cytotoxicity and antiviral activity of the new compounds were tested. Compound 3 was more active than doxorubicin against A-549, HCT-116 and MCF-7. However, compound 3 showed no activity against human liver carcinoma Hep G-2 cell line. Compounds 9 and 17b (E) showed potency near to doxorubicin against the four cell lines. The acute toxicity of compound 9 on liver cancer induced in rats was determined in vivo. Interestingly, it showed restoration activity of liver function and pathology towards normal as compared to the cancer-bearing rats induced by DENA. Compounds 17a (Z), 17b (E) and 18a (Z) were the most promising compounds for their antiviral activity against rotavirus Wa strain.
- 27 August 2015
- Published by Taylor & Francis in Journal of Enzyme Inhibition and Medicinal Chemistry
- Vol. 30 (5) , 826-845
Synthesis,in vitroandin vivoantitumor and antiviral activity of novel 1-substituted benzimidazole derivatives
A novel series of 5-nitro-1H-benzimidazole derivatives substituted at position 1 by heterocyclic rings was synthesized. Cytotoxicity and antiviral activity of the new compounds were tested. Compound 3 was more active than doxorubicin against A-549, HCT-116 and MCF-7. However, compound 3 showed no activity against human liver carcinoma Hep G-2 cell line. Compounds 9 and 17b (E) showed potency near to doxorubicin against the four cell lines. The acute toxicity of compound 9 on liver cancer induced in rats was determined in vivo. Interestingly, it showed restoration activity of liver function and pathology towards normal as compared to the cancer-bearing rats induced by DENA. Compounds 17a (Z), 17b (E) and 18a (Z) were the most promising compounds for their antiviral activity against rotavirus Wa strain.
- 1 October 2014
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 79 (21) , 10367-10377
Transition-Metal-Free Synthesis of Imidazo[2,1-b]thiazoles and Thiazolo[3,2-a]benzimidazoles via an S-Propargylation/5-exo-dig Cyclization/Isomerization Sequence Using Propargyl Tosylates as Substrates
A transition-metal-free route for the synthesis of several N-fused heterocycles, including thiazolo[3,2-a]benzimidazoles and imidazo[2,1-b]thiazoles, is reported. The reaction between propargyl tosylates and 2-mercaptobenzimidazoles under basic conditions results in 3-substituted thiazolo[3,2-a]benzimidazoles, in yields up to 92% in a single synthesis step. With 2-mercaptoimidazoles as the substrate, the corresponding imidazo[2,1-b]thiazoles were exclusively obtained. The transformation is considered to proceed as an intermolecular S-propargylation that is followed by 5-exo-dig ring closure and double-bond isomerization.
- 1 October 2014
- Published by American Chemical Society (ACS) in The Journal of Organic Chemistry
- Vol. 79 (21) , 10367-10377
Transition-Metal-Free Synthesis of Imidazo[2,1-b]thiazoles and Thiazolo[3,2-a]benzimidazoles via an S-Propargylation/5-exo-dig Cyclization/Isomerization Sequence Using Propargyl Tosylates as Substrates
A transition-metal-free route for the synthesis of several N-fused heterocycles, including thiazolo[3,2-a]benzimidazoles and imidazo[2,1-b]thiazoles, is reported. The reaction between propargyl tosylates and 2-mercaptobenzimidazoles under basic conditions results in 3-substituted thiazolo[3,2-a]benzimidazoles, in yields up to 92% in a single synthesis step. With 2-mercaptoimidazoles as the substrate, the corresponding imidazo[2,1-b]thiazoles were exclusively obtained. The transformation is considered to proceed as an intermolecular S-propargylation that is followed by 5-exo-dig ring closure and double-bond isomerization.
- 1 September 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (35) , 5682-5695
Assembly of 4H-chromenes, imidazobenzothiazines and quinazolines via copper-catalyzed domino reactions using 2-halobenzyl tosylates as substrates
- 1 September 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (35) , 5682-5695
Assembly of 4H-chromenes, imidazobenzothiazines and quinazolines via copper-catalyzed domino reactions using 2-halobenzyl tosylates as substrates
- 1 May 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (18) , 3061-3072
Copper-catalyzed domino reaction between 1-(2-halophenyl)methanamines and amidines or imidates for the synthesis of 2-substituted quinazolines
- 1 May 2014
- Published by Elsevier in Tetrahedron
- Vol. 70 (18) , 3061-3072
Copper-catalyzed domino reaction between 1-(2-halophenyl)methanamines and amidines or imidates for the synthesis of 2-substituted quinazolines
- 1 December 2012
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (24) , 6989-7001
Synthesis and docking studies of novel antitumor benzimidazoles
- 1 December 2012
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 20 (24) , 6989-7001
Synthesis and docking studies of novel antitumor benzimidazoles